XML 35 R25.htm IDEA: XBRL DOCUMENT v3.19.2
Share-Based Compensation Plans (Tables)
6 Months Ended
Jun. 30, 2019
Share-Based Compensation Plans  
Schedule of Company's stock option activity

The following table summarizes the Company’s stock option activity for the six-month period ended June 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

 

 

Average

 

Remaining

 

Aggregate

 

 

 

 

Exercise

 

Contractual

 

Intrinsic

 

    

Shares

    

Price

    

Term (Years)

    

Value*

Outstanding at December 31, 2018

 

1,173,620

 

$

27.96

 

  

 

 

  

Granted

 

2,500

 

$

28.77

 

  

 

 

  

Exercised

 

(18,795)

 

$

27.75

 

  

 

 

  

Forfeited or expired

 

(2,750)

 

$

31.94

 

  

 

 

  

Outstanding at June 30, 2019

 

1,154,575

 

$

27.95

 

3.7

 

$

505,000

Exercisable at June 30, 2019

 

673,092

 

$

26.89

 

1.9

 

$

284,000


*The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of the Company’s stock on June 28 2019, the last trading day of the quarter, of $26.71 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.

Schedule of Company's stock option exercise activity

The following table summarizes the Company’s stock option exercise activity for the three and six months ended June 30, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 

 

Six Months Ended June 30, 

 

    

2019

    

2018

    

2019

    

2018

 

 

(Dollars in thousands)

Total intrinsic value of stock options exercised

 

$

77

 

$

2,549

 

$

88

 

$

3,050

Net proceeds from stock option exercises

 

$

154

 

$

1,164

 

$

161

 

$

4,048

Income tax benefit from the exercise of stock options

 

$

20

 

$

663

 

$

23

 

$

793

 

Schedule of Company's restricted stock award

The following table summarizes the Company’s restricted stock award activity for the six-month period ended June 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

Shares of

 

Average

 

Remaining

 

Aggregate

 

 

Restricted

 

Grant Date

 

Contractual

 

Intrinsic

 

    

Stock

    

Fair Value

    

Term (Years)

    

Value*

Non-vested at December 31, 2018

 

61,480

 

$

30.74

 

  

 

 

  

Issued

 

600

 

 

28.77

 

  

 

 

  

Vested

 

 –

 

 

 –

 

  

 

 

  

Forfeited

 

 –

 

 

 –

 

  

 

 

  

Non-vested at June 30, 2019

 

62,080

 

$

30.72

 

2.2

 

$

1,658,000


*The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of the Company’s stock on June 28, 2019, the last trading day of the quarter, of $26.71 multiplied by the number of non-vested restricted shares outstanding.